BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2552016)

  • 1. Solubilization and characterization of sigma-receptors from guinea pig brain membranes.
    Kavanaugh MP; Parker J; Bobker DH; Keana JF; Weber E
    J Neurochem; 1989 Nov; 53(5):1575-80. PubMed ID: 2552016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine.
    Kavanaugh MP; Tester BC; Scherz MW; Keana JF; Weber E
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2844-8. PubMed ID: 2833756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
    Hellewell SB; Bowen WD
    Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
    Karbon EW; Naper K; Pontecorvo MJ
    Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
    Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of sigma-type and phencyclidine receptors.
    Adams JT; Teal PM; Sonders MS; Tester B; Esherick JS; Scherz MW; Keana JF; Weber E
    Eur J Pharmacol; 1987 Oct; 142(1):61-71. PubMed ID: 2826177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brain.
    Chaki S; Okuyama S; Ogawa S; Tanaka M; Muramatsu M; Nakazato A; Tomisawa K
    Life Sci; 1996; 59(16):1331-40. PubMed ID: 8876662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma receptors regulate contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin.
    Campbell BG; Scherz MW; Keana JF; Weber E
    J Neurosci; 1989 Oct; 9(10):3380-91. PubMed ID: 2552032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.
    Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D
    J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
    de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
    FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
    Georg A; Friedl A
    J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
    Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
    Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
    Bailey MA; Karbon EW
    Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
    Georg A; Friedl A
    Glia; 1992; 6(4):258-63. PubMed ID: 1464457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of binding sites for [3H]-DTG, a selective sigma receptor ligand, in the sheep pineal gland.
    Abreu P; Sugden D
    Biochem Biophys Res Commun; 1990 Sep; 171(2):875-81. PubMed ID: 2169739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor.
    Kahoun JR; Ruoho AE
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1393-7. PubMed ID: 1311097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro evaluation of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: high-affinity ligands for the N,N'-di-o-tolylguanidine-labeled sigma binding site.
    Mewshaw RE; Sherrill RG; Mathew RM; Kaiser C; Bailey MA; Karbon EW
    J Med Chem; 1993 Feb; 36(3):343-52. PubMed ID: 8426363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.